Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71fa8c8e56feb6f3f7a6facea5a82d84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81013e05048c1896a39568dcf0e89daf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57339361bde86b327144e94027a13306 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
filingDate |
2011-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dbc06f20f44bdfb68db0896cc4a4b19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62f1b0332bcb3099a5a410b28fe2310 |
publicationDate |
2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013022608-A1 |
titleOfInvention |
FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
abstract |
Monoclonal antibodies that are full-length IgG-isotype immunoglobulins and that are characterized by a high broad-range neutralizing activity against the influenza A virus and capable of recognizing a specific hemagglutinin epitope that is highly conserved among different influenza A virus subtypes are provided. Also provided are therapeutic, prophylactic and diagnostic uses of such immunoglobulins. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10392432-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096657-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11230593-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513553-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11453714-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800835-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877200-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689436-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012128684-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969794-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2536956-C1 |
priorityDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |